Supplementary Figure S8 from Targeting AKR1B10 by Drug Repurposing with Epalrestat Overcomes Chemoresistance in Non–Small Cell Lung Cancer Patient-Derived Tumor Organoids
Year: 2024
Type: supplementary-materials
Abstract: Supplementary Figure S8. Quantification of AKR1B10 expression in resistant and sensitive PDTOs and matched patient tumor tissues.
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4402200820
